GCC Innovation-Portfolio Board Adviser

The mandate

The board repeatedly asks why the India GCC produces many innovation demonstrations but few capabilities adopted into funded global products. Local teams are rewarded for showcases, product leaders see unowned integration cost, and partnerships introduce unclear IP and data rights. The standing question is how India-originated experiments should earn sponsorship, evidence and product commitment without suppressing exploration.

Ten monthly portfolio surgeries form the working cadence, with two adviser days reserved for interrogating hypotheses, adoption evidence and sponsor choices. Four scheduled product-and-investment committee sessions and four field reviews across India or global product hubs are covered. Urgent intellectual-property or stop-funding dilemmas receive a reasoned challenge within forty-eight hours; ordinary experiment papers are returned before the next surgery.

This ten-month appointment closes after the final portfolio disposition and board learning review. If directors want scrutiny during subsequent product scaling, the chair must table a separately scoped renewal with fresh independence evidence; continuation is neither presumed nor bundled into the retainer. Capacity not used in a particular month lapses because challenge must accompany live funding decisions.

The adviser holds no line authority and carries no executive, product, funding, IP, partnership or people responsibility. Management owns experiments and product adoption, while directors decide portfolio capital. The adviser may challenge thesis, evidence and stage gates, but cannot select teams, award funds, negotiate partners or promise global product inclusion.

Independence will be examined against every experiment entering a gate, not only at appointment. Any economic interest in a candidate startup, venture vehicle, incubator, university laboratory, model supplier or rival consumer platform constitutes a conflict that must be declared before papers are opened, and the chair may require abstention. Introductions cannot generate referral consideration, carried interest or success-linked remuneration.

Why the board wants this voice

The committee sees energetic innovation reporting without a common measure of learning, product fit or adoption cost. Global product leaders control scale decisions and may discount ideas they did not sponsor, while India teams optimise for visibility. An independent portfolio builder can help directors create fair evidence gates and protect both exploratory freedom and capital discipline.

What you will own

• Press management to state portfolio theses tied to consumer problems, strategic capability and India-specific advantage.
• Test experiments for falsifiable hypotheses, decision value, data rights, integration owner and plausible product route.
• Challenge demonstration metrics using user evidence, technical risk, product adoption cost and retained learning.
• Shape gates for discovery, prototype, controlled product test, global sponsorship, scale and deliberate closure.
• Examine incentives for local teams, global product sponsors, partners and leaders when an experiment is stopped or adopted.
• Probe IP, data, model, supplier, startup and university dependencies before portfolio commitment.
• Frame the board’s closing portfolio view with scale, continue, pivot, combine and stop decisions.

Candidate qualifications

• Governed an India GCC innovation portfolio whose strongest experiments entered funded roadmaps across several global consumer products.
• Converted polished demonstrations into falsifiable tests with named adoption owners, customer evidence, integration effort and stop criteria.
• Closed a politically visible initiative when evidence failed, while retaining its learning and protecting the team’s willingness to explore.
• Resolved intellectual-property, training-data and publication boundaries across corporate engineers, startups and university laboratories before prototype access.
• Balanced India-originated product insight with global architecture, brand and investment governance during genuinely contested sponsorship choices.
• Challenged directors independently of venture funds, accelerators, technology vendors and founders seeking capital or privileged portfolio access.

Non-negotiables

• Can attend four Sydney committee dates and complete four India or product-hub reviews within ten months.
• Will disclose platform, startup, fund, university, provider and partner relationships.
• Accepts that funding, IP, product and people authority remains with management and the board.
• Brings GCC-to-global product adoption evidence; hackathon or accelerator programme management alone is insufficient.

1. 49 words maximum. Describe an India GCC experiment you stopped despite strong demonstration metrics.
2. 49 words maximum. Which current startup, fund, university or provider relationship could require your recusal?
3. 49 words maximum. Confirm the Sydney cadence and name the evidence gate before a global product funds adoption.